Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 9, 2014, Pages 3997-4003

  Tezcan, Seda ^a   Ozgur, Didem ^a   Ulger, Mahmut ^a   Aslan, Gonul ^a   Gurses, Iclal ^a   Serin, Mehmet Sami ^a   Giray, Burcu Gurer ^a   Dilek, Saffet ^a   Emekdas, Gurol ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Consensus PCR; Cycle sequencing; E6 E7 mRNA; Genotype; Human papillomavirus; Turkish women

Indexed keywords

E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; MESSENGER RNA; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN E7; REPRESSOR PROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; BIOSYNTHESIS; CLASSIFICATION; CYTOLOGY; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; TURKEY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; RNA, MESSENGER; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; TURKEY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84902675152     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.9.3997     Document Type: Article

References (41)

1. Abike F, Bingol B, Yilmaz A, et al (2013). HPV Infection and HPV Subtypes in Normal and Abnormal Cervical Cytology in Turkish Women. J Virology&Microbiology, 640873.
2. Akcali S, Goker A, Ecemis T, Kandiloglu AR, Sanlidag T (2013). Human papilloma virus frequency and genotype distribution in a Turkish population. Asian Pac J Cancer Prev, 14, 503-6.
3. Batmaz G, Cetin A, Dane C, Gorgen H, Dane B (2009). HPV DNA positivity in women with normal and abnormal cervical smears. Turk J Gynecol Oncol, 1, 10-4.
4. Benevolo M, Terrenato I, Mottolese M, et al (2011). Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients. Cancer Causes Control, 22, 869-75.
5. Bosch FX, Broker TR, Forman D, et al (2013). Comprehensive control of human papillomavirus infections and related diseases. Vaccine, 31, 1-31.
6. Chen Q, Luo ZY, Lin M, et al (2012). Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province. Asian Pac J Cancer Prev, 13, 1519-24.
7. Ciesielska U, Nowińska K, Podhorska-Okołów M, Dziegiel P (2012). The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus. Adv Clin Exp Med, 21, 235-44.
8. Coutlée F, Rouleau D, Ferenczy A, Franco E (2005). The laboratory diagnosis of genital human papillomavirus infections. Can J Infect Dis Med Microbiol, 16, 83-91.
9. Doorbar J, Quint W, Banks L, et al (2012). The biology and life-cycle of human papillomaviruses. Vaccine, 30, 55-70.
10. Dursun P, Ayhan A, Mutlu L, et al (2013). HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Derg, 29, 210-6.
11. Ergunay K, Misirlioglu M, Firat P, et al (2008). Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities. Mikrobiyol Bul, 42, 273-82.
12. Evander M, Edlund K, Gustafsson A, et al (1995). Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis, 171, 1026-30.
13. Gibb RK, Martens MG (2011). The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol, 4, 2-11.
14. Giorgi Rossi P, Benevolo M, Vocaturo A, et al (2013). Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study. PLoS One, 8, 57600.
15. Guan P, Howell-Jones R, Li N, et al (2012). Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer, 131, 2349-59.
16. Hamzi Abdul Raub S, Isa NM, Zailani HA, et al (2014). Distribution of HPV genotypes in cervical cancer in multi-ethnic Malaysia. Asian Pac J Cancer Prev, 15, 651-6.
17. Jastreboff AM, Cymet T (2002). Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J, 78, 225-8.
18. Jeantet D, Schwarzmann F, Tromp J, et al (2009). NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses. J Clin Virol, 45, 29-37.
19. Kitchener HC, Denton K, Soldan K, Crosbie EJ (2013). Developing role of HPV in cervical cancer prevention. BMJ, 347, 4781.
20. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011). Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer, 128, 927-35.
21. Lin CY, Chen HC, Lin RW, et al (2007). Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods, 140, 1-9.
22. Lin CY, Chao A, Yang YC, et al (2008). Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol, 42, 361-7.
23. Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989). The use of polymerase reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7, 209-14.
24. Meijer CJ, Snijders PJ, Castle PE (2006). Clinical utility of HPV genotyping. Gynecol Oncol, 103, 12-7.
25. Muñoz N, Bosch FX, de Sanjosé S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
26. Muñoz N, Bosch FX, Castellsagué X, et al (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 111, 278-85.
27. Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northest Thailand. Asian Pac J Cancer Prev, 14, 6961-4.
28. Ozturk S, Kaleli I, Kaleli B, Bir F (2004). Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay. Mikrobiyol Bul, 38, 223-32.
29. Pannier-Stockman C, Segard C, Bennamar S, et al (2008). Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol, 42, 353-60.
30. Ronco G, Giorgi Rossi P (2008). New paradigms in cervical cancer prevention: opportunities and risks. BMC Womens Health, 8, 23.
31. Sahiner F, Kubar A, Yapar M, et al (2014). Detection of major HPVs by a new multiplex real-time PCR assay using type-specific primers. J Microbiol Methods, 97, 44-50.
32. Shen-Gunther J, Yu X (2011). HPV molecular assays: defining analytical and clinical performance characteristics for cervical cytology specimens. Gynecol Oncol, 123, 263-71.
33. Schiffman M, Herrero R, Desalle R, et al (2005). The carcinogenicity of human papillomavirus types reflects viral evolution. Virology, 337, 76-84.
34. Snijders PJ, van den Brule AJ, Schrijnemakers HF, et al (1990). The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol, 71, 173-81.
35. Spathis A, Kottaridi C, Chranioti A, et al (2012). mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics. PLoS One, 7, 49205.
36. Speich N, Schmitt C, Bollmann R, Bollmann M (2004). Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol, 53, 125-8.
37. Turki R, Sait K, Anfinan N, Sohrab SS, Abuzenadah AM (2013). Prevalence of human papillomavirus in women from Saudi Arabia. Asian Pac J Cancer Prev, 14, 3177-81.
38. Villa LL, Denny L (2006). Methods for detection of HPV infection and its clinical utility. Int J Gynaecol Obstet, 94, 71-80.
39. Wang L, Dai SZ, Chu HJ, Cui HF, Xu XY (2013). Integration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia. Asian Pac J Cancer Prev, 14, 3837-41.
40. Yildirim D, Yildirim ME, Bakici MZ (2013). Human papillomavirus positivity and frequency of genotypes in servical samples of women living in Sivas Region. Firat Med J, 18, 94-97.
41. Yuce K, Pinar A, Salman MC, et al (2012). Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospital-based study. Arch Gynecol Obstet, 286, 203-8.